Press Releases

Dec 28, 2021

PharmaCyte Biotech Successfully Completes 36 Month Master Cell Bank Stability Study

Dec 15, 2021

PharmaCyte Biotech Reports Second Quarter 2021 Financial Results and Operational Highlights

Dec 8, 2021

PharmaCyte Biotech Successfully Completes Cytochrome P450 Site of Integration DNA Sequencing Assay

Nov 30, 2021

PharmaCyte Biotech Launches Malignant Ascites Program with Commencement of Pivotal Preclinical Study

Nov 12, 2021

PharmaCyte Biotech Announces Cell Encapsulation Technology Material Does Not Cause Skin Irritation

Sep 27, 2021

PharmaCyte Biotech Announces Encapsulation Material Does Not Alter Cellular DNA

Sep 21, 2021

PharmaCyte Biotech Releases More Positive Results From FDA-Required Biocompatibility Tests

Sep 16, 2021

PharmaCyte Biotech Announces Positive Results of Biocompatibility Study for FDA

Sep 8, 2021

PharmaCyte Biotech to Participate in H.C. Wainwright 23rd Annual Global Investment Conference

Aug 31, 2021

PharmaCyte Biotech Establishes 18-Month Shelf Life for Clinical Trial Product in Ongoing Stability Study